From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 513,723 shares, representing 2.24% for $0.54 million under the buyback announced on January 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8023 USD | -0.41% | -10.10% | -97.04% |
May. 21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
May. 20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.04% | 798K | |
+37.74% | 723B | |
+34.64% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.64% | 244B | |
+9.65% | 208B | |
-4.58% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- SBFM Stock
- News Sunshine Biopharma, Inc.
- Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.